Share the Science
Free Educational Series (Webinars and Live Events)

Share the Science is a unique webinar series dedicated to the cord blood industry. Share the Science is always free and open to the public. Learn more about this exciting educational series bringing you the latest in research and industry best practices.

What is Share the Science?

Save The Cord Foundation and WellSky (formerly known as Mediware) have teamed up to provide the cellular therapy industry with an exclusive speaker series to discuss the topics in which you and your peers are most interested.  Join us as we feature today’s leaders in cord blood research and cord blood transplants.  Learn about the latest developments in the cord blood industry by participating in discussions with our speakers as they present their latest research, opinions on industry news and so much more.
​
These cord blood webinars are free and open to the general public; however, we do advise that the series focuses on the more technical aspects of cord blood research happening today as our speakers present their latest findings. Each session is recorded live and then archived for future viewing (some exceptions apply). ​

View the Archive:

Please note all of the links below will direct you to our archives.
Some of these archives are held on Mediware’s site, sponsor of our Share the Science series.

• Recording coming soon. Dr. Timothy Nelson: Strengthening the HLHS Heart with Cord Blood – Cutting edge research at the MAYO Clinic is leading to new hope for individuals with HLHS Heart Syndrome and cord blood is a critical part of the story. Can cord blood strengthen the heart? Dr. Timothy Nelson discusses his latest research in this in-depth webinar.
  
  
• Dr. Moshe Israeli: Stem Cell Donor Search in the Global Village: What Lies Ahead? – Dr. Israeli explores the growing complexity of global stem cell searches and the impact genetics is playing in creating new challenges. He explains the challenges of finding a suitable matched donor and the new promise of using cord blood for much needed transplants.
  
  
• Additional Information Upon Request:  Dr. Miguel-Angel Perales: Immune System Reconstitution Post Stem Cell Transplant – In this live presentation at BMT Tandem 2017, Dr. Perales discussed immune reconstitution following HCT, with a particular emphasis on factors that contribute to delayed immune recovery post transplant, including graft source, and the clinical consequences.
  
  
• Dr. Charles Cox, Jr. : Cellular Therapies for Neurological Injuries – Recently, Dr. Cox completed the first acute, autologous cell therapy treatment Phase I study for traumatic brain injury in children (aged 5-14). In this webinar, Dr. Cox speaks about cellular therapies for neurological injuries, preclinical and early clinical trials occurring in the field, and future outlooks.
  
  
• Dr. Colleen Delaney: Applications for Expanded Cord Blood Progenitor Cells – Dr. Delaney’s research interests focus on the role of the Notch signaling pathway in hematopoietic stem cell regulation and ex-vivo expansion of umbilical cord blood stem and progenitor cells for clinical applications. Her research has led to the establishment of NoHLA Therapeutics, Inc. which is focused on developing off-the-shelf, universal donor therapies that require no HLA matching.
  
  
• Linda Peltier, PhD:  Improve Operating Costs & Maximize Potential of Cord Blood – “How to Potentialize Cord Blood Banks?” Cord blood banking standards are becoming more strict. Upfront investments for both public and private are significant. How can the cord blood industry do things better? Reduce operating costs while improving standards?
  
  
• Additional Information Upon Request:  Dr. Wise Young: Cord Blood Therapies as Potential Treatments for People with Chronic Spinal Cord Injury –  At this exclusive live presentation, Dr. Young discussed his latest research results based on clinical trials he is running in China, Taiwan and Hong Kong using umbilical cord blood mononuclear cells and lithium to potentially treat spinal cord injuries. Also see our recorded interview with Dr. Young here.
  
  
• Morey Kraus: Perinatal Stem Cells from Umbilical Cord Tissue to Potentially Treat Newborns with Hypoxic Ischemic Injuries – This webinar provides an understanding of what perinatal stem cells are and are not as well as methods of isolation, characterization, and storage. Mr. Kraus speaks on the potential use of perinatal stem cells from umbilical cord tissue and their potential use in newborns with hypoxic ischemic injuries.
  
  
• Dr. Maria Craig: Can we prevent or cure Type 1 Diabetes with cord blood? – In Australia, Dr. Craig and her team are undertaking a world-first study, the CoRD study, to assess whether the unique cells found in cord blood can actually stop the immune destruction in the pancreas and protect a child from developing the disease. Dr. Craig discusses her findings and on-going research in this fascinating webinar.
  
  
• Dr. Curtis Cetrulo, Sr. Women’s Health: Perinatal Stem Cells in Regenerative Medicine – Dr. Cetrulo, Sr. discusses the importance of perinatal stem cells and the impact they will have on treating a variety of diseases. In particular, Dr. Cetrulo, Sr. discusses how he anticipates that in the near future people who go to emergency rooms with chest pain, with the presumptive diagnosis of a heart attack, or myocardial infarction (MI), will be given an off-the-shelf stem cell preparation to prevent heart muscle damage.
  
  
• Dr. Bernard Thébaud: Recycling Matters – Cord-Derived Stem Cell Treatment of Neonatal Diseases – Dr. Bernard Thébaud, neonatologist at the Children’s Hospital of Eastern Ontario and a senior scientist with the Ottawa Hospital Research Institute and Children’s Hospital of Eastern Ontario Research Institute, discusses using cord blood derived stem cell therapy to improve lung disease and repair organ damage in premature infants.
  
  
• Dr. Phyllis I. Warkentin: A First Look at the NetCord-FACT 6th Edition Cord Blood Standards – Dr. Phyllis I. Warkentin, Chief Medical Officer of the Foundation for the Accreditation of Cellular Therapy (FACT), discusses the 6th edition NetCord-FACT Standards that will be published in July 2016.
  
  
• Dr. Heidi Elmoazzen: Maximizing Opportunities for Transplant: Strategies to Improve the Quality of Cord Blood Inventory – Dr. Heidi Elmoazzen, director of the Cord Blood Bank and Stem Cell Manufacturing of Canadian Blood Services, discuss strategies to improve the quality of inventory in cord blood banks and strategies to increase the utilization of banked cord blood units.
  
  
• Additional Information Upon Request: Insight into the first US clinical trials “Using Cord Blood in Autism” by Dr. Michael Chez (Originally presented live at the BMT Tandem Meetings 2016. Sorry, there is not a recording available of this presentation.)
  
  

• Recorded Webinar with Dr. James Baumgartner: Autologous Cord Blood Stem Cell Applications for Pediatric Stroke and Acquired Hearing Loss
  Watch the recorded webinar to hear Dr. James Baumgartner, Surgical Director, Comprehensive Pediatric Epilepsy Center, Florida Hospital for Children, speak about using cord blood to treat acquired hearing loss and perinatal stroke in children.
  
  

• Additional Information Upon Request:  Dr. Joanne Kurtzberg “Game Changers: Cord Blood Helps the Brain” (Originally presented live at the 2015 AABB Conference. Sorry, there is not a recording available of this presentation.)
  
  

• Recorded Webinar with Dr. Susana G. Gomez: Quality Cord in Cord Blood Banking
  Watch the recorded webinar to hear Dr. Susana Gomez, Director of the Cord Blood Bank at Anthony Nolan Cell Therapy Centre in the UK, speak about quality cord in cord blood banking.
  
  

• Share the Science with Kate Girard: Novel Applications for Newborn Stem Cells: Exploring Regenerative Properties  Watch the recorded webinar to hear Kate Girard, Director of Clinical Affairs and Regenerative Medicine at ViaCord, speak about the novel applications for newborn stem cells, current regenerative medicine applications of cord blood stem cells, and potential future applications of cord-tissue-derived stem cells.
  
  

• Share the Science with Dr. Wayne McIlwraith: Using Stem Cells to Treat Joint Injury and Osteoarthritis in Horses and its Translational Relevance to Humans  Watch the recorded webinar to hear Dr. Wayne McIlwraith, a Distinguished Professor at Colorado State University, speak about the use of stem cells to treat joint injury and osteoarthritis in horses and its translational relevance to humans.
  
  

• Share the Science with Michael Boo: How to Build an Effective National Inventory of Publicly Available Cord Blood Units  Watch the recorded webinar to hear Michael Boo, Chief Strategy Officer of the National Marrow Donor Program (NMDP), speak on how to build a more effective national inventory of publicly available cord blood units.
  
  

• Share the Science with Sharon Miller: FDA Licensure of HPC, Cord Blood: How Licensure Has Improved Cord Blood Banking  Watch the recorded webinar to hear Sharon Miller, Director of Regulatory Affairs at ClinImmune Labs, speak about the positive effects of FDA licensure on HPC, Cord Blood, and how licensure has improved cord blood banking.
  
  

• Share the Science with Dr. Curtis Cetrulo: Stem Cells and Immunologic Tolerance Induction for Hand and Face Transplantation  Watch the recorded webinar to hear Dr. Curtis Cetrulo, Reconstructive Plastic Surgeon and Stem Cell Researcher from Massachusetts’s General Hospital, speak about the amazing advancements surrounding transplanted limbs and reconstructive cosmetic surgeries using stem cells.
  ​

• Share the Science with Dr. Joanne Kurtzberg: Cord Blood Transplantation for Genetic and Acquired Brain Diseases  Watch the recorded webinar to hear Dr. Joanne Kurtzberg, M.D., speak about cord blood transplantation for genetic and acquired brain diseases.